Neuropsychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.6 | Q1 | 94.9% | 2.988 | Q1 | 97.6% |
| 2024 | 7.1 | Q1 | 95.1% | 2.944 | Q1 | 97.6% |
| 2023 | 6.6 | Q1 | 93.6% | 2.743 | Q1 | 97.4% |
| 2022 | 7.6 | Q1 | 91.2% | 2.385 | Q1 | 96.8% |
| 2021 | 8.3 | Q1 | 92.7% | 2.277 | Q1 | 96.7% |
| 2020 | — | — | 2.704 | Q1 | 97.4% | |
| 2019 | — | — | 3.122 | Q1 | 97.9% | |
| 2018 | — | — | 3.205 | Q1 | 97.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1740-634X
ISSN
0893-133X
country
CHcoverage
1987-2026